Chicago Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Chicago Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-129,225	Closed	-$5.14M	–	36
2026 Q1	$5.14M	Buy	+129,225	New	+$5.31M	4.26%	12

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Chicago Capital Management's TERN Position: Q2 2026 in Review

Chicago Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 129,225 shares — an estimated $5.14M sold.

Chicago Capital Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $5.14M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Chicago Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Chicago Capital Management sold 129,225 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.14M.
Chicago Capital Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Chicago Capital Management's Terns Pharmaceuticals position peaked at $5.14M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.